Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Oxidative Medicine and Cellular Longevity|July 12, 2013
Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorderCinzia Signorini, Claudio De Felice, Thierry Durand, et al.Neurochemical Research|July 20, 2010
The physiological behaviour of IMR-32 neuroblastoma cells is affected by a 12-h hypoxia/24-h reoxygenation periodCarlo Aldinucci, Silvia Maria Maiorca, Paola De Rosa, et al.Mediators of Inflammation|January 24, 2014
Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of Rett syndrome patientsAlessandra Pecorelli, Guido Leoni, Franco Cervellati, et al.Free Radical Biology & Medicine|May 26, 2009
Systemic oxidative stress in classic Rett syndromeClaudio De Felice, Lucia Ciccoli, Silvia Leoncini, et al.Proteomics. Clinical Applications|June 2, 2016
Expression and oxidative modifications of plasma proteins in autism spectrum disorders: Interplay between inflammatory response and lipid peroxidationAlessio Cortelazzo, Claudio De Felice, Roberto Guerranti, et al.Antioxidants (Basel, Switzerland)|July 13, 2018
Isoprostanoids in Clinical and Experimental Neurological Disease ModelsCinzia Signorini, Claudio De Felice, Jean-Marie Galano, et al.Oxidative Medicine and Cellular Longevity|August 4, 2015
Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAsSilvia Leoncini, Claudio De Felice, Cinzia Signorini, et al.Mediators of Inflammation|February 11, 2014
Subclinical inflammatory status in Rett syndromeAlessio Cortelazzo, Claudio De Felice, Roberto Guerranti, et al.Mediators of Inflammation|February 15, 2014
Effects of ω-3 PUFAs supplementation on myocardial function and oxidative stress markers in typical Rett syndromeSilvia Maffei, Claudio De Felice, Pierpaolo Cannarile, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|May 3, 2011
F₄-neuroprostanes mediate neurological severity in Rett syndromeCinzia Signorini, Claudio De Felice, Silvia Leoncini, et al.Pageof 7